Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular Characteristics and Prognostic Analysis of Low-Risk Acute Myeloid Leukemia with Relapse].

Zhongguo shi yan xue ye xue za zhi - 1 Dec 2025

Gao Yun-Fei, Tan Ye-Hui, Su Long, Lin Hai, Gao Su-Jun, Liu Xiao-Liang

Abstract excerpt

OBJECTIVE: To investigate the molecular characteristics of low-risk acute myeloid leukemia (AML) at recurrence, and analyze the factors affecting retreatment efficacy and prognosis. METHODS: A retrospective analysis was conducted on the clinical and laboratory data of 31 patients with newly diagnosed low-risk AML who relapsed during consolidation treatment or follow-up after treatment in our hospital from April...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to fms-Like Tyrosine Kinase 3
Share to DNMT3A gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Share to Recurrence

Share to Risk Factors

Source

Identifiers

PMID: 41502247
DOI: 10.19746/j.cnki.issn.1009-2137.2025.06.001

Genes

DNMT3A
FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular Characteristics and Prognostic Analysis of Low-Risk Acute Myeloid Leukemia with Relapse].PMID 41502247Read ↗

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?Semantic proximity Read ↗

Outcomes and genetic dynamics of acute myeloid leukemia at first relapse.Semantic proximity Read ↗

Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomesSemantic proximity Read ↗

Biology of post-transplant relapse: actionable features.Semantic proximity Read ↗

Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemiaSemantic proximity Read ↗

Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.Semantic proximity Read ↗

Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.Semantic proximity Read ↗

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

[Clinical and biological prognostic factors in relapsed acute myeloid leukemia patients].Semantic proximity Read ↗

Genetic and epigenetic heterogeneity and the impact on cancer relapse.Semantic proximity Read ↗

The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.